Analyst Ratings for Apellis Pharmaceuticals (APLS)
APLS Rating Summary
APLS Price Target Summary
- Highest: $52.00 (Baird)
- Lowest: $19.00 (Goldman Sachs)
- Average: $33.65
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.65 (+67.6%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 61%
Avg. $ Target:
$33.65 (+67.6%)
* Over Last 12-Mos
Rating Score: 5.7 / 10
Percentile Rank: 61%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Equalweight (N/A) |
24.00 (N/A) |
21.99 (20.07) |
-8.73% | Details |
| 1/21/2026 | BofA Securities | Tazeen Ahmad | Upgrade | Buy (Neutral) |
28.00 (N/A) |
20.47 (20.07) |
-1.95% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
